DGX heads into Q4 earnings with expected revenue and EPS growth, DIS momentum, and benefits from Fresenius assets and ...

Jan Burnett thinks her routine blood tests are behind her when she receives an explanation of benefits showing zero patient ...

Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...

Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. | Quest ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Quest expects the new blood test will support response monitoring in clinical trials.

If you have been wondering whether Quest Diagnostics at around US$185 per share is a fair deal or a stretch, you are not alone. The stock has returned 0.5% over the last 7 days, 6.5% over the past ...

Quest Diagnostics reaffirmed as a buy: organic growth, macro demand, strong margins, investment-grade ratings, and dividend ...

Quest Diagnostics may be the preferred lab your health insurance, doctors, or specialists use for blood work or other samples. We’re reviewing its sub-brand Quest Health, from which you can order your ...

Corewell Health Southfield and Quest Diagnostics have completed a previously announced transaction to establish a laboratory ...

In the last three months, 7 analysts have published ratings on Quest Diagnostics (NYSE:DGX), offering a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary ...